We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Interferon-Induced Protein Protects Against Recurring Influenza Infections

By LabMedica International staff writers
Posted on 14 Feb 2013
Following infection of the body by the influenza virus, protective immune cells called resident memory T-cells (TRM cells) are stationed in lung and respiratory mucosal tissues where they express a specific membrane protein that helps prevent reinfection.

Investigators at the University of Melbourne (Australia) reported in the January 27, 2013, online edition of the journal Nature Immunology that infection with influenza virus resulted in the deposition of anti-influenza CD8+ TRM cells in the lung mucosal tissue. More...
These TRM cells selectively maintained expression of the interferon-induced transmembrane protein IFITM3 (interferon-induced transmembrane protein 3).

IFITM3 is an interferon-induced membrane protein that helps confer immunity to influenza A H1N1 virus, West Nile virus, and Dengue virus. It has been reported to play a critical role in the immune system's defense against swine flu, where heightened levels of IFITM3 kept viral levels low, and the removal of IFITM3 allowed the virus to multiply unchecked. This observation was further advanced by a recent study that showed that a single nucleotide polymorphism (SNP) in the human IFITM3 gene that increased influenza susceptibility was overrepresented in people hospitalized with pandemic H1N1.

“If we learn how to increase the number and longevity of T-cells expressing IFITM3, this could lead to improved vaccines that promote the generation of more resistant T-cells able to provide the greatest protection, for longer,” said senior author Dr. JoseVilladangos, professor of microbiology and immunology at the University of Melbourne.

Related Links:
University of Melbourne



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.